Stephen Gottschalk, MD, on CAR T Cells for Solid Tumors: What Are the Challenges?

2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Tweet this page

Stephen Gottschalk, MD, of Baylor College of Medicine and Texas Children’s Hospital, discusses combining CAR T cells with checkpoint blockade or targeted treatments to improve their antitumor activity in solid tumors.

Advertisement

Advertisement



Advertisement